There was a difference in one variable, the percentage of CD14++CD16− monocytes, which was lower in the <9 years IBD duration subgroup compared with the longer disease duration subgroup (26.82 vs. 37.09 median, p = 0.025) (Table 1). Here, CD14 is linked to inflammatory bowel disease.